|Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.|
Nat Genet. 46, 176-81., 2014
|Mutation of CEBPA in familial acute myeloid leukemia|
ML Smith, JD Cavenagh, TA Lister, J Fitzgibbon
New England Journal of Medicine 351 (23), 2403-2407, 2004
|BLUEPRINT to decode the epigenetic signature written in blood|
D Adams, L Altucci, SE Antonarakis, J Ballesteros, S Beck, A Bird, C Bock, ...
Nature biotechnology 30 (3), 224-226, 2012
|Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias|
J Fitzgibbon, LL Smith, M Raghavan, ML Smith, S Debernardi, ...
Cancer research 65 (20), 9152-9154, 2005
|Mutation of the Wilms’ tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical …|
P Virappane, R Gale, R Hills, I Kakkas, K Summers, J Stevens, C Allen, ...
Journal of Clinical Oncology 26 (33), 5429-5435, 2008
|The International Human Epigenome Consortium: a blueprint for scientific collaboration and discovery|
HG Stunnenberg, S Abrignani, D Adams, M de Almeida, L Altucci, V Amin, ...
Cell 167 (5), 1145-1149, 2016
|Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy|
CJ Owen, CL Toze, A Koochin, DL Forrest, CA Smith, JM Stevens, ...
Blood, The Journal of the American Society of Hematology 112 (12), 4639-4645, 2008
|Familial myelodysplasia and acute myeloid leukaemia–a review|
C Owen, M Barnett, J Fitzgibbon
British journal of haematology 140 (2), 123-132, 2008
|EZH2 mutations are frequent and represent an early event in follicular lymphoma.|
Blood 122 (18), 3165-3168, 2013
|Transformation of follicular lymphoma to diffuse large B‐cell lymphoma proceeds by distinct oncogenic mechanisms|
AJ Davies, A Rosenwald, G Wright, A Lee, KW Last, DD Weisenburger, ...
British journal of haematology 136 (2), 286-293, 2007
|Paralogy Mapping: Identification of a Region in the Human MHC Triplicated onto Human Chromosomes 1 and 9 Allows the Prediction and Isolation of NovelPBXandNOTCHLoci|
N Katsanis, J Fitzgibbon, EMC Fisher
Genomics 35 (1), 101-108, 1996
|Follicular lymphomas with and without translocation t (14; 18) differ in gene expression profiles and genetic alterations|
E Leich, I Salaverria, S Bea, A Zettl, G Wright, V Moreno, RD Gascoyne, ...
Blood 114 (4), 826-834, 2009
|Transformation of indolent B-cell lymphomas|
S Montoto, J Fitzgibbon
Journal of clinical oncology 29 (14), 1827-1834, 2011
|Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma|
KE Summers, LK Goff, AG Wilson, RK Gupta, TA Lister, J Fitzgibbon
Journal of Clinical Oncology 19 (2), 420-424, 2001
|Spectral tuning and molecular evolution of rod visual pigments in the species flock of cottoid fish in Lake Baikal|
DM Hunt, J Fitzgibbon, SJ Slobodyanyuk, JK Bowmakers
Vision research 36 (9), 1217-1224, 1996
|Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular …|
E Carlotti, D Wrench, J Matthews, S Iqbal, A Davies, A Norton, J Hart, ...
Blood 113 (15), 3553-3557, 2009
|Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2|
J Snaddon, ML Smith, M Neat, M Cambal‐Parrales, A Dixon‐McIver, ...
Genes, Chromosomes and Cancer 37 (1), 72-78, 2003
|A novel K509I mutation of KIT identified in familial mastocytosis—in vitro and in vivo responsiveness to imatinib therapy|
LY Zhang, ML Smith, B Schultheis, J Fitzgibbon, TA Lister, JV Melo, ...
Leukemia research 30 (4), 373-378, 2006
|Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML|
K Summers, J Stevens, I Kakkas, M Smith, LL Smith, F Macdougall, ...
Leukemia 21 (3), 550-551, 2007
|The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer …|
D O'Shea, C O'Riain, C Taylor, R Waters, E Carlotti, F MacDougall, ...
Blood, The Journal of the American Society of Hematology 112 (8), 3126-3129, 2008